Skinvisible, Inc.
SKVI
$0.23
-$0.07-23.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| SG&A Expenses | 589.10K | 527.20K | 516.80K | 486.90K | 491.70K |
| Depreciation & Amortization | 20.50K | 20.10K | 18.70K | 18.70K | 18.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 609.60K | 547.40K | 535.50K | 505.60K | 510.30K |
| Operating Income | -589.60K | -527.40K | -515.50K | -485.60K | -490.30K |
| Income Before Tax | -565.60K | -1.18M | -1.19M | -1.16M | -2.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.57 | -1.18 | -1.19 | -1.16 | -2.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -565.60K | -1.18M | -1.19M | -1.16M | -2.38M |
| EBIT | -589.60K | -527.40K | -515.50K | -485.60K | -490.30K |
| EBITDA | -569.10K | -507.20K | -496.80K | -466.90K | -471.70K |
| EPS Basic | -0.15 | -0.26 | -0.26 | -0.26 | -0.52 |
| Normalized Basic EPS | -0.16 | -0.16 | -0.16 | -0.16 | -0.33 |
| EPS Diluted | -0.15 | -0.26 | -0.26 | -0.26 | -0.52 |
| Normalized Diluted EPS | -0.16 | -0.16 | -0.16 | -0.16 | -0.33 |
| Average Basic Shares Outstanding | 20.25M | 18.16M | 18.16M | 18.16M | 18.16M |
| Average Diluted Shares Outstanding | 20.35M | 18.26M | 18.26M | 18.16M | 18.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |